Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Income from Continuing Operations: 2020-2024

Historic Income from Continuing Operations for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$45.9 million.

  • Burning Rock Biotech's Income from Continuing Operations rose 62.43% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year increase of 78.00%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • Burning Rock Biotech's Income from Continuing Operations amounted to -$45.9 million in FY2024, which was up 49.80% from -$91.4 million recorded in FY2023.
  • Burning Rock Biotech's Income from Continuing Operations' 5-year high stood at -$45.9 million during FY2024, with a 5-year trough of -$140.2 million in FY2022.
  • In the last 3 years, Burning Rock Biotech's Income from Continuing Operations had a median value of -$91.4 million in 2023 and averaged -$92.5 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 99.86% in 2021, then soared by 49.80% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Income from Continuing Operations (MRY) stood at -$62.4 million in 2020, then plummeted by 99.86% to -$124.7 million in 2021, then dropped by 12.43% to -$140.2 million in 2022, then surged by 34.83% to -$91.4 million in 2023, then soared by 49.80% to -$45.9 million in 2024.
  • Its Income from Continuing Operations was -$45.9 million in FY2024, compared to -$91.4 million in FY2023 and -$140.2 million in FY2022.